Floatz logo

Veliparib

Brain Stem Glioma

National Cancer Institute (NCI)Small moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Brain Stem Glioma cohort.

Asset / SponsorPhaseRating
L-METHIONINE
St. Jude Children's Research Hospital
Phase 2CCC
RITONAVIR
Case Comprehensive Cancer Center
Phase 2CCC
Lopinavir
Case Comprehensive Cancer Center
Phase 2CCC
Therapeutic Allogeneic Lymphocytes
City of Hope Medical Center
Phase 1CC

Same molecule, other indications

Veliparib is also rated in:

non-small cell lung carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Stage IV Pancreatic CancerDormant
BB
Indicative ·
71 / 100
View asset →
small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →